Improve accuracy of lung cancer invasiveness diagnosis during surgery
Part of Cancer clinical trials.
This trial looks to improve how doctors judge how “invasive” a small lung adenocarcinoma is while you’re having surgery. Better accuracy may help guide treatment decisions for people with early-stage, operable lung cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a CT scan within 3 months before your lung surgery
- You are age 20 to 80, and your lung cancer is operable and stage I
- Your lung tumor is under 3 cm, measured on thin CT slices
- Your tumor is confirmed as lung adenocarcinoma after surgery by pathology (tissue testing)
- You have not had cancer treatment before (in the lungs or elsewhere)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to decide which lymph nodes to remove during lung cancer surgery. The goal is to make surgery more precise and reduce side effects while still effectively removing cancer.
This study looks at whether people with a very early type of lung cancer can safely have curative surgery when their CT scan shows a ground-glass type spot with certain size and shape measurements. It aims to help doctors choose the right surgery approach based on the scan features and final pathology.
This trial is testing a lung-sparing surgery called segmentectomy for people with a certain type of lung cancer nodule. It aims to see if this surgery is a good option for those with solid-dominant nodules that are 2 to 3 cm in size and have not spread to lymph nodes.
This study looks back at medical records and CT scans of people with early-stage lung cancer to find patterns that help predict if cancer cells may spread through air spaces. This could help doctors plan better treatments for patients like you.
This trial tests whether a computer program that creates a 3D model of your lungs from a CT scan helps doctors plan your lung surgery more precisely. The goal is to make the surgery safer and more effective.
This trial tests a special imaging technique that uses a harmless dye to help surgeons see the exact boundary between healthy and diseased lung tissue during surgery to remove a small part of the lung. This could help make the surgery more precise and potentially preserve more healthy lung.
Hear when a new Lung Adenocarcinoma, Stage I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.